Patients

OMass Therapeutics, a UK BioTech company developing small molecule therapeutics against highly validated target ecosystems, announced an oversubscribed €275 million (£230 million) Series C round. The round was co-led by…

Penelope Health, a real-time provider and payer policy intelligence platform out of London, today announced a funding commitment of €87 million ($100 million), as well as a partnership with HealthTech…

For millions of people living with dementia, quality of life often takes a drastic turn downward. But it doesn’t have to be that way. Agrace Hospice is planning a new…